Dr Michael Green Explains the Link Between Monocyte-Like Cells, Neurotoxicity After CAR T Therapy
The cells associated with neurotoxicity syndrome following chimeric antigen receptor T-cell therapy were most like conventional monocytes, explained Michael R. Green, PhD, associate professor of lymphoma and myeloma and director, Translational and Laboratory Research, Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, when discussing study results on the use of Yescarta (axicabtagene ciloleucel) for diffuse large B-cell lymphoma.
